Specific Gut Microbial Enzymes Drive Colitis Promotion by Triclosan

ABSTRACT: Triclosan (TCS), an antimicrobial agent in thousands of consumer products, is a risk factor for colitis and colitis-associated colorectal cancer. While the intestinal toxicities of TCS require the presence of gut microbiota, the molecular mechanisms involved have not been defined. Here we show that intestinal commensal microbes mediate metabolic activation of TCS in the colon and drive its gut toxicology. Using a range of in vitro, ex vivo, and in vivo approaches, we identify specific microbial β-glucuronidase (GUS) enzymes involved and pinpoint molecular motifs required to metabolically activate TCS in the gut. Finally, we show that targeted inhibition of bacterial GUS enzymes abolishes the colitis-promoting effects of TCS, supporting the essential roles of specific microbial proteins in TCS toxicity. Our results define a mechanism by which intestinal microbes cause the gut toxicity of environmental chemicals and suggest a therapeutic approach to alleviate colitis and associated diseases.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Human Gut Metagenome

TISSUE(S): Feces

SUBMITTER: Morgan Walker  

LAB HEAD: Matthew R. Redinbo

PROVIDER: PXD025887 | Pride | 2021-11-04

REPOSITORIES: Pride